Eye disease treatment developer Sight Sciences prices 10M-share IPO at $24

Sight Sciences (SGHT) priced its initial public offering of 10 million common shares at $24.00 per share, for a total gross revenues of $240 million. Trading will begin on July 15th. The over-allotment of underwriters is a…/nRead More